v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Stockholders' Equity (Deficit)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Treasury stock, at cost
Balance at Dec. 31, 2024   $ 50,121 $ 14 $ 912,241 $ (862,106) $ 665 $ (693)
Balance (in Shares) at Dec. 31, 2024     131,136,712        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of RSUs (in shares)     828,282        
Exercise of common stock options   232   232      
Exercise of common stock options (in shares)     77,515        
Exercise of common warrants   517   517      
Exercise of common warrants (in shares)     239,201        
Reclassification of warrant liability to common stock warrants   1,241   1,241      
Stock-based compensation expense   6,283   6,283      
Issuance of common warrants   5,766   5,766      
Net loss   (58,579)     (58,579)    
Foreign currency translation adjustment   992       992  
Balance at Mar. 31, 2025   6,573 $ 14 926,280 (920,685) 1,657 (693)
Balance (in Shares) at Mar. 31, 2025     132,281,710        
Balance at Dec. 31, 2024   50,121 $ 14 912,241 (862,106) 665 (693)
Balance (in Shares) at Dec. 31, 2024     131,136,712        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss $ (121,774)            
Foreign currency translation adjustment 3,141            
Balance at Jun. 30, 2025   (47,215) $ 15 933,537 (983,880) 3,806 (693)
Balance (in Shares) at Jun. 30, 2025     133,014,673        
Balance at Mar. 31, 2025   6,573 $ 14 926,280 (920,685) 1,657 (693)
Balance (in Shares) at Mar. 31, 2025     132,281,710        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of RSUs   1 $ 1        
Vesting of RSUs (in shares)     361,918        
Issuance of RSAs (in shares)     120,265        
Exercise of common stock options   1,190   1,190      
Exercise of common stock options (in shares)     220,687        
Exercise of common warrants   65   65      
Exercise of common warrants (in shares)     30,093        
Stock-based compensation expense   2,762   2,762      
Change in estimate of issuance of 2028 common warrants   3,240   3,240      
Net loss (63,195) (63,195)     (63,195)    
Foreign currency translation adjustment 2,149 2,149       2,149  
Balance at Jun. 30, 2025   (47,215) $ 15 933,537 (983,880) 3,806 (693)
Balance (in Shares) at Jun. 30, 2025     133,014,673        
Balance at Dec. 31, 2025   (86,235) $ 15 961,991 (1,051,359) 3,811 (693)
Balance (in Shares) at Dec. 31, 2025     135,372,269        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of RSUs (in shares)     655,061        
Issuance of RSAs (in shares)     4,545        
Exercise of common stock options   250   250      
Exercise of common stock options (in shares)     26,194        
Exercise of common warrants   13   13      
Exercise of common warrants (in shares)     1,500        
Stock-based compensation expense   7,403   7,403      
Net loss   (10,621)     (10,621)    
Foreign currency translation adjustment   (777)       (777)  
Balance at Mar. 31, 2026   (89,967) $ 15 969,657 (1,061,980) 3,034 (693)
Balance (in Shares) at Mar. 31, 2026     136,059,569        
Balance at Dec. 31, 2025   (86,235) $ 15 961,991 (1,051,359) 3,811 (693)
Balance (in Shares) at Dec. 31, 2025     135,372,269        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (44,376)            
Foreign currency translation adjustment (960)            
Balance at Jun. 30, 2026   334,500 $ 18 1,428,059 (1,095,735) 2,851 (693)
Balance (in Shares) at Jun. 30, 2026     166,997,792        
Balance at Mar. 31, 2026   (89,967) $ 15 969,657 (1,061,980) 3,034 (693)
Balance (in Shares) at Mar. 31, 2026     136,059,569        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Vesting of RSUs (in shares)     327,486        
Issuance of RSAs (in shares)     67,950        
Exercise of common stock options   2,771   2,771      
Exercise of common stock options (in shares)     539,556        
Exercise of common warrants   169,648 $ 1 169,647      
Exercise of common warrants (in shares)     14,839,902        
Redemption of common warrants   3   3      
Reclassification of warrant liability to common stock warrants   3,918   3,918      
Stock-based compensation expense   4,987   4,987      
Issuance of shares for 2028 Notes conversion   277,078 $ 2 277,076      
Net loss (33,755) (33,755)     (33,755)    
Foreign currency translation adjustment $ (183) (183)       (183)  
Balance at Jun. 30, 2026   $ 334,500 $ 18 $ 1,428,059 $ (1,095,735) $ 2,851 $ (693)
Balance (in Shares) at Jun. 30, 2026     166,997,792        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of shares for 2028 Notes conversion (in shares)     15,163,329